Target hemoglobin level for EPO therapy in CKD

Am J Kidney Dis. 2006 Jan;47(1):171-3. doi: 10.1053/j.ajkd.2005.11.001.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Anemia / blood
  • Anemia / drug therapy*
  • Anemia / etiology
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Chronic Disease
  • Erythropoietin / administration & dosage
  • Erythropoietin / adverse effects
  • Erythropoietin / therapeutic use*
  • Goals
  • Hemoglobins / analysis*
  • Humans
  • Kidney Diseases / blood
  • Kidney Diseases / complications*
  • Kidney Diseases / mortality
  • Kidney Diseases / therapy
  • Kidney Failure, Chronic / blood
  • Kidney Failure, Chronic / complications
  • Kidney Failure, Chronic / mortality
  • Kidney Failure, Chronic / therapy
  • Quality of Life
  • Randomized Controlled Trials as Topic
  • Recombinant Proteins
  • Renal Dialysis / adverse effects
  • Thrombophilia / chemically induced

Substances

  • Hemoglobins
  • Recombinant Proteins
  • Erythropoietin